保健和生命科学
奥纬咨询为领先的保健及生命科学公司的六大核心领域提供咨询服务：健康保险、医药保健、保健企业风险评估和管理、医药品、生物科技和医疗设备。完全以顾客为中心的方法帮助客户制定了可行的计划，实现了卓越的成果。
Medical Devices and Drug Delivery
Understanding novel drug delivery technologies is key to unlocking the potential of both large- and small-molecule therapeutics. We help companies understand the markets, customers and partners for growth in this area, and provide expertise in the development and commercialization of these new technologies and products.
Biotechnology
Oliver Wyman conducts technical evaluations to support the development and growth of biotechnology companies, where identifying, evaluating and selecting the appropriate technology, license or partner is often key to success. In addition to providing assessment services, our firm provides strategic insight for long-term growth.
Pharmaceuticals
Scientific and deep analytics experience allows us to develop growth strategies for pharmaceutical companies in late stage product development and launch. We assist clients with clinical, go-to-market, and partner strategies, market and customer segmentation analysis, mature products life cycle management, and licensing and alliance issues.
Health Risk Management
Using our proprietary risk analysis frameworks and modeling platforms, we develop sophisticated risk management and capital allocation strategies for all types of organizations in the healthcare value chain.
Health Care Services
A wide range of national and international health care service providers, including disease management companies, drug distribution companies and TPAs, as well as private equity and investment banking clients, count on Oliver Wyman to develop tailored strategic growth projects and to conduct due diligence analysis.
Health Insurance
Our growth strategies for health insurers focus on new market entry, competitive assessment, product design, customer segmentation, channel and sales force effectiveness, and operational plan development. We provide analytical support in cost and capital management, specializing in Risk Adjusted Return on Capital (RAROC) methodologies.
